TCL Archive NIH COI Rule Mandates More Disclosure, Leaves Institutions In Charge Of Ethics Of Extramural Researchers September 16, 2011
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive HHS Drops Misconduct allegations Against NCI’s Gallo Days Before Appeals Hearing November 19, 1993
